Reveal Insider Trading for Safeway, Facebook, Cisco, Citigroup, Elan, and Myriad Genetics



Insiderslab.com is has released insider trading report to US market investors who want better performance in their investments. Today’s report will reveal the insider trading in these stocks: Safeway (NYSE:SWY), Facebook (NASDAQ:FB), Cisco (NASDAQ:CSCO), Citigroup (NYSE:C), Elan (NYSE:ELN), and Myriad Genetics (NASDAQ:MYGN).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Safeway Inc. (NYSE:SWY): By the end of last trading session, the shares of Safeway (NYSE:SWY) soared US$1.71 (or 7.40%) to US$24.82 with 41.99 million shares exchanged hands, compared to daily average volume of 4.77 million. Insiderslab.com found company Senior Vice President, Jerry Tidwell, sold his shares at price of US$25.39. Investors may want to find out how Safeway insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for SWY here.
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/SWY/Safeway.pdf
 
Facebook Inc (NASDAQ:FB): By the end of last trading session, Facebook (NASDAQ:FB) shares lost US$0.04 (or 0.17%) to US$23.73 with about 31.19 million shares exchanged hands for the session, compared to its average volume of 43.04 million shares. Insiderslab.com found company COO, Sheryl Sandberg, sold her shares at price of US$23.54 for about US$4.16 million on June 13, which was part of her US$27.35 million selling in the past three months. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/FB/Facebook.pdf
 
Cisco Systems, Inc. (NASDAQ:CSCO): By the end of last trading session, Cisco (NASDAQ:CSCO) earned US$0.36 (or 1.50%) to US$24.35 with about 27.24 million shares exchanged hands for the session, compared to its average volume of 46.55 million shares. Insiderslab.com found insiders sold his/her shares at price of US$21.49 – US$24.58 for about US$57.05 million within the last three months. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Cisco are starting to sell more company shares. See insider trade report for CSCO here.
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/CSCO/Cisco.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Citigroup Inc (NYSE:C):
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/C/Citigroup.pdf
 
Elan Corporation, plc (ADR) (NYSE:ELN):
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/ELN/Elan.pdf
 
Myriad Genetics, Inc. (NASDAQ:MYGN):
 
Read Full Report: http://www.insiderslab.com/PR3/061413A/MYGN/MyriadGenetics.pdf
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Jun 14, 2013

 
More Insider News ...

Today's Notable Trades


DOVER SADDLERY INC (DOVR)
First-Class Insider (Chief Strategy Officer): Grylls Jonathan AR

Sold 38,665 Incentive Stock Option (right to buy) (Derivative security at conversion or exercise price: $1.940) on Oct 20, 2014. Direct holding 91,845 shares/units after transaction. Incentive Stock Option (right to buy) expires on Dec 29, 14. Holdings decreased -29.63%.
Filing date: Oct 22, 2014. Record updated at 18:03:17.
 
OmniAmerican Bancorp, Inc. (OABC)
Senior Officer (SEVP and CFO): Wilkinson Deborah B

Acquired 13,996 common stock (Non-Derivative security at $14.150) on Oct 20, 2014. Direct holding 52,891 shares/units after transaction. Holdings increased 35.98%.
Filing date: Oct 21, 2014. Record updated at 18:03:16.
 
ACORDA THERAPEUTICS INC (ACOR)
Senior Officer (Chief Scientifc Officer): Blight Andrew

Sold 52,338 Common Stock (Non-Derivative security at $32.076) on Oct 20, 2014. Direct holding 65,787 shares/units after transaction. Holdings decreased -44.31%.
Filing date: Oct 22, 2014. Record updated at 18:03:12.
 
MONSANTO CO /NEW/ (MON)
First-Class Insider (Chairman & CEO): GRANT HUGH

Sold 90,000 Common Stock (Non-Derivative security at $112.384) on Oct 20, 2014. Direct holding 142,000 shares/units after transaction. Holdings decreased -38.79%.
Filing date: Oct 22, 2014. Record updated at 18:03:11.
 
PENN NATIONAL GAMING INC (PENN)
Director: CARLINO PETER M

Sold 11,184 Common Stock (Non-Derivative security at $11.570) on Oct 20, 2014. Direct holding 52,034 shares/units after transaction. Holdings decreased -17.69%.
Filing date: Oct 22, 2014. Record updated at 18:03:03.
 
CEPHEID (CPHD)
Director: RENTON HOLLINGS

Sold 11,900 Common Stock (Non-Derivative security at $45.830) on Oct 20, 2014. Direct holding 10,117 shares/units after transaction. Holdings decreased -54.05%.
Filing date: Oct 22, 2014. Record updated at 18:02:58.
 
CONSTELLATION BRANDS, INC. (STZ)
Senior Officer (Exec. VP & Gen. Counsel): MULLIN THOMAS J

Sold 40,000 Class A Common Stock (Non-Derivative security at $86.251) on Oct 21, 2014. Direct holding 65,947 shares/units after transaction. Holdings decreased -37.75%.
Filing date: Oct 22, 2014. Record updated at 18:02:50.
 
RPM INTERNATIONAL INC/DE/ (RPM)
Senior Officer (VP, GC & Chief Compliance Off.): Moore Edward W.

Sold 8,762 Common Stock, $0.01 par value (Non-Derivative security at $43.610) on Oct 20, 2014. Direct holding 74,977 shares/units after transaction. Holdings decreased -10.46%.
Filing date: Oct 22, 2014. Record updated at 18:02:47.
 
Ultragenyx Pharmaceutical Inc. (RARE)
Director: Aliski William

Acquired 29,108 Common Stock (Non-Derivative security at $3.010) on Oct 20, 2014. Direct holding 66,010 shares/units after transaction. Holdings increased 78.88%.
Filing date: Oct 22, 2014. Record updated at 18:02:40.
 
ARUBA NETWORKS, INC. (ARUN)
First-Class Insider (President & C.E.O): Orr Dominic P

Sold 5,000 Common Stock (Non-Derivative security at $19.627) on Oct 21, 2014. Indirect holding 25,000 shares/units after transaction. Holdings decreased -16.67%.
Filing date: Oct 22, 2014. Record updated at 18:02:36.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.